| Name |
Sunitinib Pharmascience 12,5 mg tvrde kapsule |
| Marketing Authorisation Number |
HR-H-327190831 |
| Active Substance |
sunitinibklorid |
| Composition |
jedna kapsula sadrži 12,5 mg sunitiniba u obliku sunitinibklorida |
| Pharmaceutical Form |
Kapsula, tvrda |
| Manufacturer |
Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal |
| Marketing Authorisation Holder |
Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar |
| Marketing Authorisation Date |
08.10.2021 |
| MA Period of Validity |
08.10.2026 |
| Classification Number |
UP/I-530-09/20-01/54 |
| Registration Number |
381-12-01/154-21-04 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ograničeni recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L01EX01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
